Saltar al contenido
Merck
Todas las fotos(3)

Documentos

840058P

Avanti

Hydro Soy PC

Avanti Research™ - A Croda Brand

Sinónimos:

HSPC

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(3)

About This Item

Número de CAS:
97281-48-6
UNSPSC Code:
12352211
NACRES:
NA.25

description

L-α-phosphatidylcholine, hydrogenated (Soy)

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 1 g (840058P-1g)
pkg of 1 × 200 mg (840058P-200mg)
pkg of 1 × 25 mg (840058P-25mg)
pkg of 1 × 500 mg (840058P-500mg)

manufacturer/tradename

Avanti Research™ - A Croda Brand

lipid type

phospholipids
phosphoglycerides

shipped in

dry ice

storage temp.

−20°C

InChI

1S/C44H88NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h42H,6-41H2,1-5H3/t42-/m1/s1

InChI key

NRJAVPSFFCBXDT-HUESYALOSA-N

Application

L-α-phosphatidylcholine, hydrogenated (Soy) may be used in the lipososme generation for reconstitution of complement active human plasma, bupivacaine and dexamethasone loading.

Biochem/physiol Actions

L-α-phosphatidylcholine, hydrogenated (Soy) is naturally occurring and is majorly used in the synthesizing liposomes. It is also used in small unilamellar vesicles (SUVs) synthesis.

Packaging

30 mL Amber Wide Mouth Bottle with Screw Cap (840058P-500mg)
5 mL Amber Glass Screw Cap Vial (840058P-200mg)
5 mL Amber Glass Screw Cap Vial (840058P-25mg)
60 mL Amber Wide Mouth Screw Cap Glass Bottle (840058P-1g)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

also commonly purchased with this product

Referencia del producto
Descripción
Precios

Storage Class

11 - Combustible Solids

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes
Graham SM, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society, 178(10), 101-107 (2014)
Ankita Dadwal et al.
Journal of microencapsulation, 1-14 (2020-04-16)
Aim: The aim of this project is to improve the therapeutic effectiveness, permeation and retention of clobetasol propionate in sebaceous glands by reporting the use of Squarticles as lipidic nanosystem.Methods: Homogenisation method is used for the formulation of Squarticles (nanoemulgel)
alginate encapsulation for bupivacaine delivery and mesenchymal stromal cell immunomodulatory cotherapy
Davis MS, et al
Journal of Inflammation Research, 12(10), 87-87 (2019)
Nikolaos Naziris et al.
International journal of pharmaceutics, 574, 118849-118849 (2019-11-24)
The utilization of liposomes in biomedical applications has greatly benefited the diagnosis and treatment of various diseases. These biomimetic nano-entities have been very useful in the clinical practice as drug delivery systems in their conventional form, comprising lipids as structural
Establishing Liposome-Immobilized Dexamethasone-Releasing PDMS Membrane for the Cultivation of Retinal Pigment Epithelial Cells and Suppression of Neovascularization
Lin TW, et al.
International Journal of Molecular Sciences, 20(2), 241-241 (2019)
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico